What to expect

Learn about what to expect if you participate in the COMPARE study. This study has 4 main phases and an Optional sub-study if you're assigned to the Usual Care group.

The study requires your involvement for a minimum of 18 weeks. This may extend up to 37 weeks if you participate in the Optional sub-study.

Phase 1: Assessment

You will complete assessments of your language, communication, memory and thinking.

We will ask questions about how you feel about your communication.

The assessment will take place in private at a clinic or at your home.

There will be 2-3 assessment sessions, with each lasting for 1–2½ hours.

Phase 2: Treatment

A treatment will be offered to you. The choice of group is done randomly by a computer. The research team has no control which treatment individuals receive.

  • CIAT: some people will work on their talking for 30 hours over two weeks
  • M-MAT: some people will work on their talking, writing, drawing and gestures for 30 hours over two weeks
  • Usual care: some people will continue their normal routine and not receive extra treatment at that time.

Phase 3: Assessment

You will be re-assessed on some of the tests you completed before therapy.

This will happen in the week after treatment.

The assessment will take place in private at a clinic or at your home.

There will be 2-3 assessment sessions, lasting for 1–2½ hours.

Between this and the final assessment (12 weeks later) we will ask you to complete a diary. We will text or call you each week to remind you.

Phase 4: Follow-up assessment

Twelve weeks after treatment, you will be re-assessed on some of the tests you completed before therapy.

The assessment will take place in private at a clinic or at your home.

There will be 2-3 assessment session, lasting for 1–2½ hours.

Optional sub-study

If you were assigned to the Usual Care group you may be able to participate in the optional sub-study after the 12 week assessment period. In this sub-study you will be randomly allocated to a treatment group: CIAT or M-MAT. Your treatment will occur 3 times per week over 5 weeks.

After treatment, you will complete assessments to help the research team determine the effects of treatment. These assessments will take place immediately after the treatment and again approximately 12 weeks later.